Live Breaking News & Updates on Serious adverse event

Stay updated with breaking news from Serious adverse event. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Moleculin Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones

– Announces successful completion of the Phase 1B portion of its Phase 1B/2 clinical trial Annamycin in combination with Cytarabine for the treatment of AML...

United-kingdom , Poland , Houston , Texas , United-states , Italy , British , Tacaribe-arenavirus , Jenene-thomas , Liposomal-annamycin , Walter-klemp , European-union

Moleculin Biotech (MBRX) Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones

Moleculin Biotech (MBRX) Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Poland , United-kingdom , Italy , British , Walter-klemp , Tacaribe-arenavirus , Liposomal-annamycin , Company-core-technologies , British-journal-of-cancer-research , National-institutes-of-health , European-union , Drug-administration

Recce Pharmaceuticals Achieves Positive Phase I Clinical

Highlights: Independent examiners confirm Phase I study of RECCE® 327 (R327) in 80 human subjects across eight cohorts achieved all primary study...

United-states , Australia , Sydney , New-south-wales , John-prendergast , Jordyn-temperato , Andrew-geddes , Alanw-dunton , James-graham , Guillame-van-renterghem , Therapeutic-goods-administration , Recce-pharmaceuticals-ltd

ImmVira presented latest encouraging clinical results of two proprietary products at ASCO 2023

/PRNewswire/ -- ImmVira submitted four abstracts covering latest results from Phase I/II clinical trials of MVR-T3011 IT (intratumoral injection) and MVR-T3011...

Chicago , Illinois , United-states , China , Shenzhen , Guangdong , American , American-society-for-clinical-oncology-annual-meeting , Clinical-oncology-annual-meeting , Poster-discussions , Common-criteria

A Synopsis of the 2022 Modernization of Cosmetics Regulation Act

This article summarizes sections of the modernization act that expand cosmetic law. The United States has recently updated its cosmetic laws, adding to provisions, prohibited acts and more.

Department-of-health , Human-services , Drug-administration , Cosmetics-act , Cosmetics-regulation-act , Consolidated-appropriations-act , President-biden , Adverse-event , Serious-adverse-event , Adverse-events , Responsible-person

Omega-3 Pet Supplements Are Recalled For Potentially Lethal Reasons

The FDA has released a statement saying that Stratford Care USA, Inc is recalling 62 brands of Omega-3 supplements for cats and dogs.

Stratford-care-united-states-inc , Stratford-care-united-states , Serious-adverse-event , Vitamina-toxicity , Tratford-care-usa , Nc , Mega-3 , Da , Upplements , Ats , Ogs

Omega-3 Pet Supplements Are Recalled For Potentially Lethal Reasons

Omega-3 Pet Supplements Are Recalled For Potentially Lethal Reasons
iheart.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iheart.com Daily Mail and Mail on Sunday newspapers.

Stratford-care-united-states-inc , Stratford-care-united-states , Serious-adverse-event ,

Omega-3 Pet Supplements Are Recalled For Potentially Lethal Reasons

Omega-3 Pet Supplements Are Recalled For Potentially Lethal Reasons
iheart.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iheart.com Daily Mail and Mail on Sunday newspapers.

Stratford-care-united-states-inc , Stratford-care-united-states , Serious-adverse-event ,

First Substantial Reform of Cosmetics Law Since FDR Administration | Nelson Mullins Riley & Scarborough LLP

President Biden signed into law the Modernization of Cosmetics Regulation Act of 2022 (“MoCRA”), as part of the Consolidated Appropriations Act, 2023. This is the first major reform of...

United-states , Nelson-mullins , Paul-clowes , Drug-administration , Nelson-mullins-riley-scarborough , Nelson-mullins-riley , Cosmetics-regulation-act , Consolidated-appropriations-act , Federal-food , Cosmetic-act , Event-recording , Serious-adverse-event